Elixiron Immunotherapeutics Competitors and Similar CompaniesClear all

Elixiron Immunotherapeutics's competitors and similar companies include Anterogen and CEL-SCI.

	Elixiron Immunotherapeutics Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases.	Anterogen Anterogen is a biotech company that researches and develops cell therapy products and drugs using adult stem cells.	CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Founding Date	Founding Date 2017	Founding Date 2000	Founding Date 1983
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development therapy	Tags Healthcare biotech clinical research drug development therapy	Tags Healthcare biotech clinical research drug development therapy
Locations	Locations TW HQ	Locations KR HQ	Locations Vienna, US HQ
Employees	Employees 19	Employees N/A	Employees N/A
Financial
Net income	Net income N/A	Net income (₩1.4b) (FY, 2025)	Net income ($25.4m) (FY, 2025)

For sources of this data, please see the company profile

Anterogen is a biotech company that researches and develops cell therapy products and drugs using adult stem cells.

Vienna, US

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

Financial